World Health Organization Sounds Alert Over Severe Shortage of Obesity Jabs

Fewer than a tenth of individuals eligible to benefit from weight-loss injections like Wegovy can access them, caution the World Health Organization as it publishes its inaugural guidance on the therapies.

Considering more than one billion individuals worldwide currently living with obesity, it is calling for more widespread and fairer access to this class of drugs.

Per projections, in excess of 2,000,000,000 are projected to be living with obesity by 2030 without intervention.

"Our new guidelines affirms that obesity is a lifelong illness that can be managed with thorough and ongoing treatment," remarked the agency's head Tedros Adhanom Ghebreyesus.

High costs, insufficient output, and supply-chain constraints are significant barriers to broad availability to the jabs that can aid individuals in losing significant weight, explains the agency.

Skinny Jab Supply Crisis

Even under the current best projected outlook, the supply of such drugs could only cover approximately 100 million people – fewer than 10% of those who need them, as stated by the health organization.

The advice calls on governments and firms to increase availability, through approaches including licensing agreements.

Exclusive production rights on a key compound – the core ingredient of a leading brand – is due to expire in multiple countries in 2026.

How Obesity Injections Function

These medications imitate a body's own hormone to slow digestion, curb appetite and boost feelings of fullness so individuals eat less.

Individuals usually start to lose weight within a few weeks of commencing the once-weekly jabs.

Research suggests patients may regain a significant portion within a year of stopping the drug, as their usual appetite come back.

To be overweight or obese increases your likelihood for developing health problems, like type 2 diabetes, cardiovascular issues, brain attack, and specific malignancies.

Excess weight concerns individuals in all nations and was linked to over three and a half million fatalities worldwide in 2024, per the health agency.